# Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium

> **NCT01845818** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 183 (actual)

## Conditions studied

- Ankylosing Spondylitis
- Psoriatic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01845818
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-05
- **Primary completion:** 2017-06-23
- **Final completion:** 2017-06-23
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845818, "Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01845818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*